{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that a-Syn mutations cause PD through protein aggregation and neuronal cell death.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as a-Syn's role in neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses an in vitro model with SH-SY5Y cells overexpressing a-Syn mutants treated with rotenone/maneb.",
          "judgment": "Yes",
          "reasoning": "The assay models PD pathogenesis by assessing aggregation and neurotoxicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls include wild-type a-Syn. Multiple replicates implied through acute/chronic treatments.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Mutants compared to wild-type a-Syn. No other variants used as controls.",
          "judgment": "No",
          "reasoning": "Only wild-type is used as control."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "All mutants increase aggregation/toxicity. No statistical analysis provided.",
          "judgment": "Max PS3_supporting",
          "reasoning": "Total benign controls per variant is 1, leading to supporting strength."
        }
      ],
      "functional_evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Disease mechanism is clearly defined."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Assay applicable to PD pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls include wild-type a-Syn. Multiple replicates implied.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates present."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Mutants compared to wild-type a-Syn. No other variants used as controls.",
          "judgment": "No",
          "reasoning": "Only wild-type is control."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Same as above.",
          "judgment": "Max PS3_supporting",
          "reasoning": "Benign controls per variant are 1, leading to supporting strength."
        }
      ],
      "functional_evidence_strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Disease mechanism clearly defined."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Assay applicable to PD pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls include wild-type a-Syn. Multiple replicates implied.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates present."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Mutants compared to wild-type a-Syn. No other variants used as controls.",
          "judgment": "No",
          "reasoning": "Only wild-type is control."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Same as above.",
          "judgment": "Max PS3_supporting",
          "reasoning": "Benign controls per variant are 1, leading to supporting strength."
        }
      ],
      "functional_evidence_strength": "PS3_moderate"
    }
  ]
}